MarchVET India is a leading veterinary pharmaceutical company based in Mumbai, India, specializing in the manufacturing and export of high-quality veterinary medicines and healthcare products. With a comprehensive product portfolio tailored for livestock health, MarchVET has established itself as a trusted partner for veterinarians, animal health professionals, and agri-based enterprises across global markets.
Core Business
MarchVET operates in the veterinary pharmaceuticals segment with a focus on anthelmintics, antibiotics, antiparasitics, and injectable formulations. The company caters to the treatment and prevention of parasitic infections, bacterial diseases, and respiratory conditions in cattle, sheep, goats, poultry, and other livestock.
It is committed to ensuring effective disease management and animal productivity through quality-driven and economically viable pharmaceutical solutions.
Product & Service Offerings
The company’s extensive product portfolio includes over 30 categories of Liquid Orals, Injectables, and Bolus formulations, specifically designed for veterinary use. Notable offerings include:
-
Liquid Orals
- Albendazole (various dosages and combinations)
- Fenbendazole and Praziquantel combinations
- Rafoxanide with Ivermectin and Levamisole
- Triclabendazole with Ivermectin
- Enrofloxacin-based combinations with Bromhexine and Colistin
- Ivermectin, Closantel, Oxyclozanide-based antiparasitics
-
Injectables & Sachets
- Iso Metamidium Chloride HCL (Trypa Mar)
- Diminazene Di Aceturate (Dimi Mar)
-
Bolus
- Bithionol Sulfoxide Bolus (Misto 5)
These formulations are available in a variety of pack sizes, ranging from 30ml to 1000ml for liquid orals and sachets of 125mg to 23.6g for injectables, making them suitable for both large-scale farms and small veterinary practices.
Specialisation and USP
MarchVET’s specialization lies in its deep focus on anthelmintic combinations and antiparasitic drug delivery systems. Its R&D-driven approach allows the company to offer potent multi-active compound formulations that deliver broad-spectrum efficacy against internal and external parasites.
The company’s USP includes:
- Custom-formulated drug combinations to tackle regional parasite resistance trends.
- A comprehensive range of liquid orals, ideal for easy administration in rural and semi-urban livestock environments.
- High bioavailability and targeted delivery of multi-active formulations.
- Products manufactured under stringent Good Manufacturing Practices (GMP).
Financial Strength
Though privately held and not publicly disclosing financial data, MarchVET has demonstrated steady growth as evidenced by its expanding global footprint. The product breadth and repeat orders from clients indicate sustainable revenue channels and operational scalability.
Shipment Data
Based on international trade records from platforms like Volza and ImportYeti, MarchVET India actively exports to over 20 countries, including:
- Africa (Kenya, Tanzania, Nigeria, Uganda)
- South Asia (Nepal, Bangladesh, Sri Lanka)
- Middle East (Yemen, Iraq, Jordan)
- Latin America (Peru, Ecuador)
Exported products primarily include albendazole combinations, ivermectin-based solutions, and injectable sachets. The company processes over 150 international consignments annually, with consistent demand in high-livestock-density regions.
Target Market
MarchVET’s primary clientele includes:
- Veterinary pharmaceutical distributors
- Livestock cooperatives and animal health agencies
- Government tender suppliers
- NGOs focused on rural animal healthcare
- Exporters of veterinary supplies
The company focuses on emerging markets with a high burden of animal parasitic diseases and a growing demand for cost-effective veterinary medications.
Capabilities
MarchVET’s production and operational capabilities include:
- In-house formulation and quality control laboratories
- WHO-GMP compliant manufacturing facility
- Flexibility in product customization for different regulatory markets
- Expertise in high-volume, high-variation pharmaceutical packaging
- Export documentation and registration support for over 20 global regulatory bodies
Their logistical setup ensures quick turnaround for both domestic and international orders.
Certifications and Compliance
MarchVET adheres to the following regulatory and quality standards:
- WHO-GMP Certified
- ISO 9001:2015 for quality management systems
- Compliant with Drug Control Authority (India) and veterinary drug regulations in multiple export markets
- Products tested and validated for shelf-life stability under different climatic zones
These certifications reflect the company’s commitment to quality, consistency, and regulatory alignment.
Major Achievements
- Developed over 30+ liquid oral formulations, making it one of the most comprehensive ranges in India.
- Approved supplier for veterinary drugs in multiple African and Middle Eastern government tenders.
- Built a strong distribution network across Asia and Africa, with localized formulation variations.
- Successfully introduced multi-drug combinations like Rafoxanide + Ivermectin + Levamisole, addressing resistance and compliance challenges in parasite management.
Customer Testimonials
While public testimonials are limited, feedback from distributor networks and trade partners suggests high satisfaction in:
- Product reliability and clinical efficacy
- Wide selection of veterinary formulations
- Competitive pricing and high-volume availability
- Excellent customer service and regulatory documentation support
MarchVET is often recommended for veterinary export contracts and bulk purchases for public animal health programs.
